Searched for
QHPV
The next big advance in cancer treatment could be a vaccineResearchers predict that the next big advance in cancer treatment will be the development of vaccines to shrink tumors and stop cancer from...- 'Indian' cervical cancer vaccine to hit market soonSingh said Covid-19 had raised awareness about preventive healthcare and the development of vaccines like the one against cervical cancer w...
- Cervical Cancer Vaccine: Here's everything you should know about India's self-developed HPV vaccineIndia pharma regulator, DCGI had last month granted market authorisation to SII to manufacture the indigenously-developed vaccine against c...
- Cervical cancer vaccine to be launched in few months at affordable price: SII CEO Adar PoonawallaPoonawalla told reporters on the sidelines of the event, "The cervical cancer vaccine will be affordable and would be available in the rang...
- India to soon get first vaccine against cervical cancerThe Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India's first indigenously developed Quadriva...
- All you need to know about the upcoming cervical cancer vaccine in IndiaTo obtain a complete regimen of HPV vaccines in India, one must spend at least Rs 5,000 to Rs 8,000. A qHPV vaccine is available from Merck...
- India gets its first cervical cancer vaccine; women in their 30s remain vulnerable, must get regular check-ups doneAdar Poonawalla said that the 'affordable' qHPV will be launched later this year.
- DCGI recommends allowing SII to manufacture, stockpile qHPV vaccine against cervical cancer: SourcePrakash Kumar Singh, Director, Government and Regulatory Affairs at SII, had written to the Health Ministry on February 4 seeking approval ...
- NTAGI to review trial data on SII's qHPV vaccine against cervical cancerSerum Institute of India Director for Government and Regulatory Affairs Prakash Kumar Singh applied to the Drugs Controller General of Indi...
- SII seeks from DCGI market authorisation for India's first qHPV vaccine against cervical cancerIn the application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, director (government and regulatory affairs) at SI...
- SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancerThe Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human ...
Load More
